Table 1 |
||||
|
Immunohistochemical reagents and results |
||||
|
Results |
||||
|
Antigens |
Antibodies (clone) |
Sources |
EMEA. |
CIN3 |
|
|
||||
|
Pancytokeratin |
AE1/3 |
Dako Corp. Glostrup, Denmark |
+++ |
+++ |
|
Pancytokeratin |
CAM5.2 |
Beckton-Dickinson, CA, USA |
++ |
+ |
|
HMWCK |
34βE12 |
Dako |
+ |
+++ |
|
CK5/6 |
D5/16 |
Dako |
+ |
+++ |
|
CK7 |
N1626 |
Dako |
+ |
+ |
|
CK8 |
DC10 |
Dako |
- |
- |
|
CK14 |
LL002 |
Novocastra, Newcastle upon type, UK |
- |
- |
|
CK 18 |
DC10 |
Dako |
+++ |
- |
|
CK 19 |
RCK 108 |
Progen, Heidelberg, Germany |
++ |
- |
|
CK 20 |
K20.8 |
Dako |
- |
- |
|
EMA |
E29 |
Dako |
- |
+ |
|
Vimentin |
Vim 3B4 |
Dako |
- |
- |
|
CEA |
polyclonal |
Dako |
- |
- |
|
CA19-9 |
NS19-9 |
TBF Lab, Tokyo Japan |
+ |
+ |
|
CA125 |
NS125 |
TFB Lab |
+++ |
+ |
|
Desmin |
D33 |
Dako |
- |
- |
|
ASMA |
1A4 |
Dako |
- |
- |
|
p53 protein |
DO-7 |
Dako |
+ |
+ |
|
p63 |
4A4 |
Dako |
- |
+++ |
|
Chromogranin |
DAK-A3 |
Dako |
- |
- |
|
Synaptophysin |
Polyconal |
Dako |
- |
- |
|
CD56 |
UJ13A |
Dako |
- |
- |
|
CD68 |
KP-1 |
Dako |
- |
- |
|
ER |
M7047 |
Dako |
+++ |
+++ |
|
PgR |
1A6 |
Novocastra |
+++ |
- |
|
HER2/neu |
CB11 |
Ventana Japan, Tokyo |
- |
- |
|
MUC1 |
Ma695 |
Novocastra |
- |
+ |
|
MUC2 |
CCp58 |
Novocastra |
- |
- |
|
MUC5AC |
CLH2 |
Novocastra |
- |
- |
|
MUC6 |
CLH5 |
Novocastra |
- |
- |
|
|
||||
|
+++, strongly positive. ++, moderately positive. +, mildly positive. -, negative. EMEA, early microinvasive endometrioid adenocarcinoma. CIN3, cervical intraepithelial neoplasm grade 3. HMWCK, high molecular weight cytokeratin. CK, cytokeratin. EMA, epithelial membrane antigen. CEA, carcinoembryonic antigen. CA19-9, carbohydrate antigen 19-9. CA125, carbohydrate antigen 125. ASMA, α-smooth muscle antigen. ER, estrogen receptor. PgR, progesterone receptor. |
||||
|
Terada Diagnostic Pathology 2011 6:51 doi:10.1186/1746-1596-6-51 |
||||
